Results 51 to 60 of about 272 (99)

18F‐FAPI versus 18F‐FDG PET/CT in the Diagnosis of Relapsing Polychondritis

Clinical Case Reports, Volume 12, Issue 12, December 2024.
ABSTRACT Relapsing polychondritis (RP) is a rare immune‐mediated systemic inflammatory disease with diverse clinical manifestations. Independent involvement of the respiratory system in RP is uncommon. In the event of respiratory involvement as the initial airway‐only manifestation, the diagnosis of RP is challenging and might be delayed, and patients ...
Xiaotong Guo, Juan Chen, Qian Zhao, Ying Liu, Xiuyan Wang   +4 more
wiley   +1 more source

Refractory relapsing polychondritis: challenges and solutions

Open Access Rheumatology: Research and Reviews, 2018
Fernando Kemta Lekpa,1,2 Xavier Chevalier3 1Faculty of Health Sciences, University of Buea, Buea, 2Reheumatology Unit, Internal Medicine Department, General Hospital, Douala, Cameroon; 3Department of Rheumatology, Henri Mondor Hospital, University Paris ...
Kemta Lekpa F, Chevalier X
doaj  

A Phase 1, Single‐Dose Study to Evaluate the Pharmacokinetics and Safety of Bepirovirsen in Adults with Hepatic Impairment and Healthy Participants (B‐Assured)

Clinical Pharmacology in Drug Development, Volume 13, Issue 10, Page 1088-1097, October 2024.
Abstract Bepirovirsen is a developmental antisense oligonucleotide (ASO) for treatment of chronic hepatitis B virus infection. No pharmacokinetic (PK) studies comparing participants with hepatic impairment (HI) and healthy participants (HPs) have been conducted with ASOs.
Nadia Noormohamed, Tamara Lukic, Thomas C. Marbury, Eric J. Lawitz, Holly Prescott, Mindy Magee, Ahmed Nader, Kelong Han   +7 more
wiley   +1 more source

Síndrome de Erasmus Associada à Policondrite Recidivante: Relato de Caso / Erasmus’ Syndrome in Association with Relapsing Polychondritis: a Case Report

Revista Ciências em Saúde, 2013
Introdução: A silicoesclerodermia foi descrita pela primeira vez por Erasmus, e é consequência de uma resposta inflamatória desencadeada pela sílica, envolvendo a liberação de mediadores que causam alteração na imunidade celular e humoral, levando a ...
Jacqueline Foelkel Pignatari, Marcela Maria da Silva, Maria Zilda Cardoso, Clarissa Santos de Carvalho Ribeiro   +3 more
doaj   +1 more source

A case of VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome presenting as progressive multisystem involvement with parenchymal infiltrates following infection with Epstein Barr virus

Respirology Case Reports, Volume 12, Issue 10, October 2024.
VEXAS syndrome is a multisystem disease manifesting as progressive inflammatory sequelae, however the underlying aetiology remains unclear. This case report describes a patient diagnosed with VEXAS who developed multi‐organ inflammation, including rapidly progressive pulmonary infiltrates following infection with Epstein Barr Virus.
Jelena Solujic, Phan Nguyen, Peter Bardy, Yao Ly, Emily Lawton   +4 more
wiley   +1 more source

VEXAS syndrome: Focus on dermatological manifestations and their histopathological correlate

JEADV Clinical Practice, Volume 3, Issue 4, Page 1035-1048, September 2024.
Abstract Background VEXAS ‘Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome’ is a rare autoinflammatory syndrome, first described in October 2020 by Beck et al. It is caused by somatic mutations in the UBA1 gene, coding for the E1 enzyme, responsible for ubiquitination.
Sofie Engelen, Anne‐Catherine Dens, Frederik Staels, Rik Schrijvers, Daniel Blockmans, Steven Vanderschueren, Albrecht Betrains, F. J. Sherida H. Woei‐A‐Jin, Arno Vanstapel, Franscesca Bosisio, Petra De Haes   +10 more
wiley   +1 more source

Severe panuveitis with relapsing polychondritis

American Journal of Ophthalmology Case Reports, 2018
Purpose: Relapsing polychondritis is a rare multiorgan disease characterized by repeated episodes of inflammation and deterioration of cartilages. We report a case of relapsing polychondritis that presented with severe panuveitis. Observations: A 53-year-
Naonori Masuda, Ryoko Nishikawa, Tetsuo Ueda, Nahoko Ogata   +3 more
doaj  

Relapsing Polychondritis pada Anak

Sari Pediatri, 2016
Relapsing polychondritis (RP) adalah penyakit autoimun yang jarang terjadi. Penyakit RP ditandai dengan inflamasi jaringan kartilago berulang dan berpotensi untuk terjadi kerusakan progresif pada jaringan tersebut.
Budi Setiabudiawan, Sinta Boesoerie, Reni Ghrahani DM, Gartika Sapartini, Diana Rosifah   +4 more
doaj   +1 more source

Relapsing polychondritis after COVID‐19 vaccination

Respirology Case Reports, Volume 12, Issue 9, September 2024.
Relapsing polychondritis (RP) is a rare inflammatory disorder involving immune‐mediated destruction of cartilaginous structures. Herein, we present the first report of a strong association between COVID‐19 vaccination and the development of RP. Clinicians should be aware that RP is one of the autoimmune diseases that can develop after mRNA vaccination.
Koki Ito, Takunori Ogawa, Shunya Igarashi, Kosuke Miyai, Kimiya Sato, Akihiko Kawana, Yoshifumi Kimizuka   +6 more
wiley   +1 more source

Posterior Scleritis and Myelodisplasia in Relapsing Polychondritis- Case Report and Literature Review

Vision Pan-America, 2016
Relapsing Polychondritis (RP) is a rare, recurrent and autoimmune multisytem disorder affecting cartilaginous structures, such as: auricles, joints, nasal septum, larynx and tracheobronchial tree.
nadine sousa marques, Ana Filipa Miranda, Sandra Barros, Sónia Parreira, Nelvia Mejias, Belmira Belran, Nuno Campos, João Cardoso   +7 more
doaj   +1 more source